Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Wouter Wegdam"'
Autor:
Wouter Wegdam, Carmen A Argmann, Gertjan Kramer, Johannes P Vissers, Marrije R Buist, Gemma G Kenter, Johannes M F G Aerts, Danielle Meijer, Perry D Moerland
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e108046 (2014)
PurposeTo identify proteins and (molecular/biological) pathways associated with differences between benign and malignant epithelial ovarian tumors.Experimental proceduresSerum of six patients with a serous adenocarcinoma of the ovary was collected be
Externí odkaz:
https://doaj.org/article/034990b2eb1c49cca4433dc419d364d4
Publikováno v:
Gynecological Surgery, 18(1):2. Springer Verlag
Zilver, S J M, Wegdam, W & Hooker, A B 2021, ' Dissection of the uterine wall in a scarred uterus: a case report ', Gynecological Surgery, vol. 18, no. 1, 2 . https://doi.org/10.1186/s10397-021-01083-w
Zilver, S J M, Wegdam, W & Hooker, A B 2021, ' Dissection of the uterine wall in a scarred uterus: a case report ', Gynecological Surgery, vol. 18, no. 1, 2 . https://doi.org/10.1186/s10397-021-01083-w
Uterine rupture is a potentially fatal complication during pregnancy, delivery, or postpartum. Women attempting a trial of labor after a cesarean section have an increased risk of a subsequent rupture. We report a case of a 24-year-old woman, gravida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4969db904dc163fd304aa0413656625d
https://research.vumc.nl/en/publications/bdec1896-186c-4b9d-a773-521fa5d6146a
https://research.vumc.nl/en/publications/bdec1896-186c-4b9d-a773-521fa5d6146a
Autor:
Johannes M. F. G. Aerts, Marri Verhoek, Timothy M. Cox, Elena Pavlova, Wilma E. Donker-Koopman, Rolf G. Boot, Jessica K. Nelson, Gert Jan Kramer, Wouter W. Kallemeijn, Mary Teresa Moran, Wouter Wegdam, Roelof Ottenhoff, Jon D. Laman, Marco van Eijk, Paulo Gaspar, Tanit L. Gabriel, Johannes P. C. Vissers
Publikováno v:
FEBS Open Bio
FEBS Open Bio, 6(9), 902-913. Wiley-Blackwell
FEBS Open Bio, 6(9), 902-913. Wiley Open Access
FEBS open bio, 6(9), 902-913. Wiley-Blackwell
FEBS Open Bio, 6(9), 902-913. Wiley-Blackwell
FEBS Open Bio, 6(9), 902-913. Wiley Open Access
FEBS open bio, 6(9), 902-913. Wiley-Blackwell
Gaucher disease is caused by inherited deficiency of lysosomal glucocerebrosidase. Proteome analysis of laser-dissected splenic Gaucher cells revealed increased amounts of glycoprotein nonmetastatic melanoma protein B (gpNMB). Plasma gpNMB was also e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9904b801f366cbc06c3d1033778f123c
https://www.repository.cam.ac.uk/handle/1810/289591
https://www.repository.cam.ac.uk/handle/1810/289591
Autor:
Herman S. Overkleeft, Johannes M. F. G. Aerts, Josanne Cox-Brinkman, Martin D. Witte, Carla E. M. Hollak, Johanna E. M. Groener, Gabor E. Linthorst, Ben J. H. M. Poorthuis, Wouter Wegdam, Rolf G. Boot, Mariëlle J. van Breemen, Nick Dekker, Henrik Gold, Gijs A. van der Marel, Gert Jan Kramer, Wouter W. Kallemeijn, Maria J. Ferraz, Saskia M. Rombach
Publikováno v:
Journal of Inherited Metabolic Disease, 34(3), 605-619. SPRINGER
Journal of inherited metabolic disease, 34(3), 605-619. Springer Netherlands
Journal of Inherited Metabolic Disease
Journal of inherited metabolic disease, 34(3), 605-619. Springer Netherlands
Journal of Inherited Metabolic Disease
A biomarker is an analyte indicating the presence of a biological process linked to the clinical manifestations and outcome of a particular disease. In the case of lysosomal storage disorders (LSDs), primary and secondary accumulating metabolites or
Autor:
Johannes P. C. Vissers, Danielle Meijer, Wouter Wegdam, Johannes M. F. G. Aerts, Marrije R. Buist, Carmen Argmann, Perry D. Moerland, Gert Jan Kramer, Gemma G. Kenter
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 9, p e108046 (2014)
PLoS ONE, 9(9), e108046-(12 p.). Public Library of Science
PLoS ONE, Vol 9, Iss 9, p e108046 (2014)
PLoS ONE, 9(9), e108046-(12 p.). Public Library of Science
PurposeTo identify proteins and (molecular/biological) pathways associated with differences between benign and malignant epithelial ovarian tumors.Experimental proceduresSerum of six patients with a serous adenocarcinoma of the ovary was collected be
Autor:
Marrije R. Buist, Boris Bleijlevens, Wouter Wegdam, Chris G. de Koster, Emiel Ver Loren van Themaat, Johannes M. F. G. Aerts, Huub C. J. Hoefsloot, Perry D. Moerland
Publikováno v:
Proteome Science, 7, 19
Proteome Science, 7. BioMed Central
Proteome Science, Vol 7, Iss 1, p 19 (2009)
Proteome Science
Proteome science, 7(1), 19-(17 p). BioMed Central
Proteome Science, 7. BioMed Central
Proteome Science, Vol 7, Iss 1, p 19 (2009)
Proteome Science
Proteome science, 7(1), 19-(17 p). BioMed Central
Background Mass spectrometry is increasingly being used to discover proteins or protein profiles associated with disease. Experimental design of mass-spectrometry studies has come under close scrutiny and the importance of strict protocols for sample
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1598a3156cd153b753e89e318ecb739a
https://hdl.handle.net/1887/62696
https://hdl.handle.net/1887/62696
Autor:
Wouter Wegdam, Johannes M. F. G. Aerts, Laura van Dussen, Richard R. Sprenger, Mariëlle J. van Breemen, Shreyas M. de Jong, Dave Speijer, Johannes P. C. Vissers, Huub C. J. Hoefsloot, Age K. Smilde, Carla E. M. Hollak, Chris G. de Koster, Rolf G. Boot
Publikováno v:
Expert Review of Proteomics, 6(4), 411-419. Taylor and Francis Ltd.
Boot, R G, van Breemen, M J, Wegdam, W, Sprenger, R R, de Jong, S, Speijer, D, Hollak, C E M, van Dussen, L, Hoefsloot, H C J, Smilde, A K, de Koster, C G, Vissers, J P C & Aerts, J M F G 2009, ' Gaucher disease: a model disorder for biomarker discovery ', Expert Review of Proteomics, vol. 6, no. 4, pp. 411-9 . https://doi.org/10.1586/epr.09.54
Boot, R G, van Breemen, M J, Wegdam, W, Sprenger, R R, de Jong, S, Speijer, D, Hollak, C E M, van Dussen, L, Hoefsloot, H C J, Smilde, A K, de Koster, C G, Vissers, J P C & Aerts, J M F G 2009, ' Gaucher disease: a model disorder for biomarker discovery ', Expert Review of Proteomics, vol. 6, no. 4, pp. 411-9 . https://doi.org/10.1586/epr.09.54
Udgivelsesdato: 2009-Aug Gaucher disease is an inherited lysosomal storage disorder, characterized by massive accumulation of glucosylceramide-laden macrophages in the spleen, liver and bone marrow as a consequence of deficient activity of glucocereb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c42270743e701d9db5b35967f557985
https://dare.uva.nl/personal/pure/en/publications/gaucher-disease-a-model-disorder-for-biomarker-discovery(1a25f337-7f9e-4b84-b6c6-5fb22f398a44).html
https://dare.uva.nl/personal/pure/en/publications/gaucher-disease-a-model-disorder-for-biomarker-discovery(1a25f337-7f9e-4b84-b6c6-5fb22f398a44).html
Autor:
J.M.F.G. Aerts, J.P. Vissers, Gemma G. Kenter, G. Kramer, D. Meijer, P.D. Moerland, J. Langridge, S.M. de Jong, M.R. Buist, Wouter Wegdam
Publikováno v:
Annals of Oncology. 23:v18-v19
Purpose Using label-free UPLC-MSE quantification methods to identify proteins as well as determining their abundance in serum and microdissected ovarian cancer tissue. Methods Serum of six patients with a serous adenocarcinoma of the ovary (stage III
Autor:
Hans Aerts, Johannes P. C. Vissers, Wouter Wegdam, Perry D. Moerland, Danielle Meijer, James I. Langridge, Shreyas M. de Jong, Marrije R. Buist, Gemma G. Kenter, Gert Jan Kramer
Publikováno v:
Cancer Research. 72:4800-4800
Purpose: Using label-free UPLC-MSE quantification methods to identifying proteins as well as determining their abundance in serum and microdissected ovarian cancer tissue. Experimental procedures: Serum of six patients with a serous adenocarcinoma of
Autor:
Perry D. Moerland, Johannes P. C. Vissers, Johannes M. F. G. Aerts, James I. Langridge, Marrije R. Buist, Gert Jan Kramer, Shreyas M. de Jong, Wouter Wegdam, Gemma G. Kenter
Publikováno v:
Cancer Research. 70:3980-3980
Purpose To search for potential protein markers or activated pathways which play a role in ovarian cancer. Experimental procedures Serum of six patients with a serous adenocarcinoma of the ovary (stage IIIB or higher) was collected before treatment.